Skip to main content
Clinical Trials/NCT00590291
NCT00590291
Terminated
Not Applicable

Genetic Studies of Coronary Artery Disease and Arteriovenous Malformation (GeneQuest) Molecular Determinants of Coronary Artery Disease

John Barnard1 site in 1 country1,461 target enrollmentJanuary 1995

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Coronary Artery Disease
Sponsor
John Barnard
Enrollment
1461
Locations
1
Primary Endpoint
Coronary Artery Disease
Status
Terminated
Last Updated
4 years ago

Overview

Brief Summary

The purpose of this study is to discover genes that may cause Coronary Artery Disease (CAD) or Arteriovenous Malformation (AVM).

Detailed Description

The purpose of this study is to discover genes that may cause Coronary Artery Disease (CAD) or Arteriovenous Malformation (AVM). Many human diseases are inherited or passed from parent to child in families. These diseases occur because of damage to a gene(s), the genetic material that is also called DNA. Scientists can now use modern molecular techniques to locate and to find certain genes within the DNA (genetic material) of a person, and to follow their inheritance in a family. To find these disease-causing genes requires studies of many affected with the disease and their family members. The purpose of this study is to locate and to find the genes for coronary artery disease (CAD) which occurs when one or more of the arteries that carry oxygen-rich blood from your heart to the rest of your body develop blockages; or, arteriovenous malformation (AVM) which causes abnormal vascular connections between arteries and veins, particularly near the heart. Findings of the genes causing CAD and AVM will have far-reaching effect on the diagnosis, treatment, and prevention of coronary artery disease and arteriovenous malformation. These studies will lead to possible genetic diagnosis, early detection of persons at risk for developing CAD or AVM (even in the absence of symptoms), development of effective drugs, more rational and specific therapeutic interventions, treatments and ultimately, prevention of coronary heart disease. Approximately 3-5 years are required to find one human disease gene.

Registry
clinicaltrials.gov
Start Date
January 1995
End Date
April 1, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
John Barnard
Responsible Party
Sponsor Investigator
Principal Investigator

John Barnard

PI

The Cleveland Clinic

Eligibility Criteria

Inclusion Criteria

  • Males at least 45 years old and premenopausal females at least 50 years old at the time of onset of any of the following:
  • Must have a living sibling meeting the same criteria.

Exclusion Criteria

  • Substance Abuse in the absence of angiographic coronary stenosis
  • Congenital Heart Disease

Outcomes

Primary Outcomes

Coronary Artery Disease

Time Frame: 2009

Arteriovenous Malformation

Time Frame: 2009

Secondary Outcomes

  • Myocardial Infarction(2009)

Study Sites (1)

Loading locations...

Similar Trials